Search

Your search keyword '"Claris, Olivier"' showing total 569 results
Start Over Author "Claris, Olivier"
569 results on '"Claris, Olivier"'

7. Rapport 24-07. Maltraitance physique chez l’enfant : Améliorer le repérage, le diagnostic et la prise en charge dans le secteur de la santé

Author

Vazquez, Marie-Paule, primary, Hascoët, Jean-Michel, additional, Bégué, Pierre, additional, Caton, Jacques, additional, Claris, Olivier, additional, Dubousset, Jean, additional, Grimprel, Emmanuel, additional, Hermange, Marie-Thérèse, additional, Lamireau, Thierry, additional, Lebranchu, Yvon, additional, Leverger, Guy, additional, Milliez, Jacques, additional, Shenfield, Françoise, additional, and Vazquez, Marie-Paule, additional

Published
2024
Full Text
View/download PDF

8. Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial

Author

Boize, Philippe, Garabédian, Charles, Flamein, Florence, Le Lous, Maela, Beuchée, Alain, Gondry, Jean, Tourneux, Pierre, Coste-Mazeau, Perrine, Bedu, Antoine, Gallot, Denis, Coste, Karen, Chauleur, Céline, Patural, Hugues, Kayem, Gilles, Mitanchez, Delphine, Heckenroth, Hélène, Boubred, Farid, Sibiude, Jeanne, Desfrère, Luc, Bohec, Caroline, Mansir, Thierry, Koch, Antoine, Kuhn, Pierre, Tillouche, Nadia, Lapeyre, Fabrice, Perrotin, Franck, Favrais, Géraldine, Lecarpentier, Edouard, Durrmeyer, Xaxier, Equy, Véronique, Debillon, Thierry, Rigonnot, Luc, Lefoulgoc, Stéphanie, Brie, Claudia, Pagès, Anne-Sophie, Rayssiguier, Romy, Cambonie, Gilles, Cudeville, Corinne, Madeleneau, Doriane, Morel, Olivier, Hascoet, Jean-Michel, Letouzey, Vincent, Di Maio, Massimo, Salomon, Laurent J., Lapillonne, Alexandre, Schmitz, Thomas, Doret-Dion, Muriel, Sentilhes, Loic, Parant, Olivier, Claris, Olivier, Renesme, Laurent, Abbal, Julie, Girault, Aude, Torchin, Héloïse, Houllier, Marie, Le Saché, Nolwenn, Vivanti, Alexandre J, De Luca, Daniele, Winer, Norbert, Flamant, Cyril, Thuillier, Claire, Boileau, Pascal, Blanc, Julie, Brevaut, Véronique, Bouet, Pierre-Emmanuel, Gascoin, Géraldine, Beucher, Gaël, Datin-Dorriere, Valérie, Bounan, Stéphane, Bolot, Pascal, Poncelet, Christophe, Alberti, Corinne, Ursino, Moreno, Aupiais, Camille, and Baud, Olivier

Published
2022
Full Text
View/download PDF

10. Neonatal ventriculomegaly: Pathophysiology and management guided with cranial ultrasonography.

Author

Bravo, Maria Carmen, Lubian, Simón, Horsch, Sandra, Cabañas, Fernando, de Vries, Linda S., Agut, Thais, Arena, Roberta, Alarcon, Ana, Arnaez, Juan, Bartocci, Marco, Carreras, Nuria Blesa, Claris, Olivier, Dudink, Jeroen, Fumagalli, Monica, Garcia‐Alix, Alfredo, Govaert, Paul, Lubián‐López, Simón Pedro, Muehlbacher, Tobias, Parodi, Alessandro, and Pellicer, Adelina

Subjects
MEDICAL personnel, PREMATURE infants, CEREBROSPINAL fluid, ULTRASONIC imaging, NEWBORN infants, INTRAVENTRICULAR hemorrhage
Abstract

Neonatal ventriculomegaly often, but not always, follows intraventricular haemorrhage in infants born preterm. Serial cranial ultrasonography (CUS) is a very useful tool to evaluate the mechanism behind ventricular dilatation, to differentiate several types of cerebrospinal fluid retention, and to guide treatment. This review examines neonatal ventriculomegaly and its definition, pathophysiology, treatment, and prognosis from the perspective of CUS assessment. It also outlines the consensus statements formulated by the EurUS.Brain group, which are based on rounds of expert opinions on neonatal ventriculomegaly management, detailing the need and timing of ventricular access device placement, in the context of posthaemorrhagic ventricular dilation. The pathophysiology of neonatal ventriculomegaly is more complex than previously considered. CUS is a valuable, non‐invasive tool to determine pathophysiology, intervention thresholds, and prognosis in neonates with ventriculomegaly. Given new insights into the existence of glymphatics and water circulation in the cerebrum, further research in that area may bring new treatment options. What this paper adds: Cranial ultrasonography has a significant role in better understanding the complex pathophysiology of neonatal ventriculomegaly.The latest research suggests that treating posthaemorrhagic ventricular dilation in its early stages has several advantages.Proper definition, management, and a follow‐up plan are essential because they can impact the infant and their family, health care providers, educational systems, and society. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project.

Author

Monfort, Anaëlle, Cardoso, Evelina, Eap, Chin B., Ansermot, Nicolas, Crettol, Severine, Fischer Fumeaux, Céline J., Graz, Myriam Bickle, Harari, Mathilde Morisod, Weisskopf, Etienne, Gandia, Peggy, Allegaert, Karel, Annaert, Pieter, Nordeng, Hedvig, Hascoët, Jean‐Michel, Claris, Olivier, Epiney, Manuella, Ferreira, Ema, Leclair, Grégoire, Csajka, Chantal, and Panchaud, Alice

Subjects
FAT content of milk, CORD blood, BREAST milk, PERINATAL period, PREGNANT women, BREASTFEEDING
Abstract

Aims: Sertraline is frequently prescribed for mental health conditions in both pregnant and breastfeeding women. According to the limited available data, only small amounts of sertraline are transferred into human milk, yet with a large amount of unexplained interindividual variability. This study aimed to develop a population pharmacokinetic (popPK) model to describe the pharmacokinetics of sertraline during the perinatal period and explain interindividual variability. Methods: Pregnant women treated with sertraline were enrolled in the multicenter prospective cohort SSRI‐Breast Milk study. A popPK model for sertraline maternal plasma and breast milk concentrations was developed and allowed estimating the milk‐to‐plasma ratio (MPR). An additional fetal compartment allowed cord blood concentrations to be described. Several covariates were tested for significance. Ultimately, model‐based simulations allowed infant drug exposure through placenta and breast milk under various conditions to be predicted. Results: Thirty‐eight women treated with sertraline were included in the study and provided 89 maternal plasma, 29 cord blood and 107 breast milk samples. Sertraline clearance was reduced by 42% in CYP2C19 poor metabolizers compared to other phenotypes. Doubling milk fat content increased the MPR by 95%. Simulations suggested a median daily infant dosage of 6.9 μg kg−1 after a 50 mg maternal daily dose, representing 0.95% of the weight‐adjusted maternal dose. Median cord blood concentrations could range from 3.29 to 33.23 ng mL−1 after maternal daily doses between 25 and 150 mg. Conclusions: Infant exposure to sertraline, influenced by CYP2C19 phenotype and breast milk fat content, remains low, providing reassurance regarding the use of sertraline during pregnancy and breastfeeding. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Cerebral Doppler imaging in neonates: A guide for clinical application and diagnosis.

Author

Horsch, Sandra, Schwarz, Simone, Arnaez, Juan, Steggerda, Sylke, Arena, Roberta, Govaert, Paul, Agut, Thais, Alarcon, Ana, Bartocci, Marco, Benavente‐Fernández, Isabel, Bravo, Maria Carmen, Cabañas, Fernando, Carreras, Nuria Blesa, Claris, Olivier, Dudink, Jeroen, Fumagalli, Monica, Garcia‐Alix, Alfredo, Lubián‐López, Simón Pedro, Mühlbacher, Tobias, and Parodi, Alessandro

Subjects
MAGNETIC resonance angiography, MAGNETIC resonance imaging, NEONATAL intensive care units, DOPPLER ultrasonography, MAGNETIC resonance
Abstract

Cranial ultrasound reliably diagnoses many neonatal brain disorders. Adding Doppler imaging expands the spectrum by providing information on the status of the vasculature and haemodynamics that may guide further diagnostic and clinical management. Doppler imaging may identify neonates with congenital or acquired vascular abnormalities such as perinatal stroke, sinuvenous thrombosis, vein of Galen malformation, dural sinus malformation, sinus pericranii, and developmental venous anomaly. These entities may need further investigation with complementary imaging modalities such as magnetic resonance imaging and magnetic resonance angiography, or conventional angiography. This review aims to help clinicians to improve their Doppler sonography knowledge and skills in order to use this helpful tool in neonates with neurological symptoms or suspected cerebral vascular abnormalities admitted to the neonatal intensive care unit. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

19. Circumstances, causes and timing of death in extremely preterm infants admitted to NICU: The EPIPAGE‐2 study

Author

Boileau, Pascal, primary, Letouzey, Mathilde, additional, Morgan, Andrei S., additional, Lorthe, Elsa, additional, Kaminski, Monique, additional, Coquelin, Anaëlle, additional, Azria, Elie, additional, Caeymaex, Laurence, additional, Rouget, Florence, additional, Diguisto, Caroline, additional, Claris, Olivier, additional, Tosello, Barthélémy, additional, Truffert, Patrick, additional, Bétrémieux, Pierre, additional, Benhammou, Valérie, additional, Marchand‐Martin, Laetitia, additional, Goffinet, François, additional, Ancel, Pierre‐Yves, additional, and Foix‐L'Hélias, Laurence, additional

Published
2023
Full Text
View/download PDF

20. Performance of 11 Host Biomarkers Alone or in Combination in the Diagnosis of Late-Onset Sepsis in Hospitalized Neonates: The Prospective EMERAUDE Study

Author

Pons, Sylvie, primary, Trouillet-Assant, Sophie, additional, Subtil, Fabien, additional, Abbas-Chorfa, Fatima, additional, Cornaton, Elise, additional, Berthiot, Amélie, additional, Galletti, Sonia, additional, Plat, Aurélie, additional, Rapin, Stephanie, additional, Trapes, Laurene, additional, Generenaz, Laurence, additional, Brengel-Pesce, Karen, additional, Callies, Arnaud, additional, Plaisant, Franck, additional, Claris, Olivier, additional, Portefaix, Aurelie, additional, Flamant, Cyril, additional, and Butin, Marine, additional

Published
2023
Full Text
View/download PDF

24. Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Author

Hansen, Mathias Lühr, Pellicer, Adelina, Gluud, Christian, Dempsey, Eugene, Mintzer, Jonathan, Hyttel-Sørensen, Simon, Heuchan, Anne Marie, Hagmann, Cornelia, Ergenekon, Ebru, Dimitriou, Gabriel, Pichler, Gerhard, Naulaers, Gunnar, Cheng, Guoqiang, Guimarães, Hercilia, Tkaczyk, Jakub, Kreutzer, Karen B., Fumagalli, Monica, Claris, Olivier, Lemmers, Petra, Fredly, Siv, Szczapa, Tomasz, Austin, Topun, Jakobsen, Janus Christian, and Greisen, Gorm

Published
2019
Full Text
View/download PDF

25. Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants

Author

Hansen, Mathias Lühr, Pellicer, Adelina, Gluud, Christian, Dempsey, Eugene, Mintzer, Jonathan, Hyttel-Sorensen, Simon, Heuchan, Anne Marie, Hagmann, Cornelia, Dimitriou, Gabriel, Pichler, Gerhard, Naulaers, Gunnar, Cheng, Guoqiang, Vilan, Ana, Tkaczyk, Jakub, Kreutzer, Karen B., Fumagalli, Monica, Claris, Olivier, Fredly, Siv, Szczapa, Tomasz, Lange, Theis, Jakobsen, Janus Christian, and Greisen, Gorm

Published
2019
Full Text
View/download PDF

27. Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project

Author

Monfort, Anaëlle, primary, Cardoso, Evelina, additional, Eap, Chin B., additional, Fischer Fumeaux, Céline J., additional, Graz, Myriam Bickle, additional, Morisod Harari, Mathilde, additional, Weisskopf, Etienne, additional, Gandia, Peggy, additional, Allegaert, Karel, additional, Nordeng, Hedvig, additional, Hascoët, Jean-Michel, additional, Claris, Olivier, additional, Epiney, Manuella, additional, Csajka, Chantal, additional, Guidi, Monia, additional, Ferreira, Ema, additional, and Panchaud, Alice, additional

Published
2023
Full Text
View/download PDF

29. Infant exposure to Fluvoxamine through placenta and human milk:a case series - A contribution from the ConcePTION project

Author

Monfort, Anaëlle, Cardoso, Evelina, Eap, Chin B., Fischer Fumeaux, Céline J., Graz, Myriam Bickle, Morisod Harari, Mathilde, Weisskopf, Etienne, Gandia, Peggy, Allegaert, Karel, Nordeng, Hedvig, Hascoët, Jean Michel, Claris, Olivier, Epiney, Manuella, Csajka, Chantal, Guidi, Monia, Ferreira, Ema, Panchaud, Alice, Monfort, Anaëlle, Cardoso, Evelina, Eap, Chin B., Fischer Fumeaux, Céline J., Graz, Myriam Bickle, Morisod Harari, Mathilde, Weisskopf, Etienne, Gandia, Peggy, Allegaert, Karel, Nordeng, Hedvig, Hascoët, Jean Michel, Claris, Olivier, Epiney, Manuella, Csajka, Chantal, Guidi, Monia, Ferreira, Ema, and Panchaud, Alice

Abstract

Introduction: Fluvoxamine is widely used to treat depression during pregnancy and lactation. However, limited data are available on its transfer to the fetus or in human milk. This case series provides additional information on the infant exposure to fluvoxamine during pregnancy and lactation. Case presentation: Two women, aged 38 and 34 years, diagnosed with depression were treated with 50 mg fluvoxamine during pregnancy and lactation. At delivery a paired maternal and cord blood sample was collected for each woman. The first mother exclusively breastfed her child for 4 months and gave one foremilk and one hindmilk sample at 2 days and 4 weeks post-partum, whereas the second mother did not breastfeed. Results: The cord to plasma concentration ratios were 0.62 and 0.48, respectively. At 2 weeks post-partum, relative infant doses (RID) were 0.47 and 0.57% based on fluvoxamine concentrations in foremilk and hindmilk, respectively. At 4 weeks post-partum, the RIDs were 0.35 and 0.90%, respectively. The child from the first mother was born healthy and showed a normal development at the 6th, 18th and 36th month follow-ups. One of the twins from the second woman was hospitalized for hypoglycemia that was attributed to gestational diabetes and low birth weight. The second one was born healthy. Conclusion: These results suggest a minimal exposure to fluvoxamine during lactation which is in accordance with previously published data. Larger clinical and pharmacokinetic studies assessing the long-term safety of this drug during lactation and the variability of its exposure through breastmilk are warranted.

Published
2023

32. Thresholds of glycemia, insulin therapy, and risk for severe retinopathy in premature infants: A cohort study

Author

Kermorvant-Duchemin, Elsa, Le Meur, Guylène, Plaisant, Frank, Marchand-Martin, Laetitia, Flamant, Cyril, Porcher, Raphaël, Lapillonne, Alexandre, Chemtob, Sylvain, Claris, Olivier, Ancel, Pierre-Yves, and Rozé, Jean-Christophe

Subjects
Retrolental fibroplasia -- Diagnosis -- Risk factors, Insulin -- Dosage and administration, Glycemic index -- Analysis, Infants (Premature) -- Diseases -- Medical examination -- Care and treatment, Biological sciences
Abstract

Background Hyperglycemia in preterm infants may be associated with severe retinopathy of prematurity (ROP) and other morbidities. However, it is uncertain which concentration of blood glucose is associated with increased risk of tissue damage, with little consensus on the cutoff level to treat hyperglycemia. The objective of our study was to examine the association between hyperglycemia and severe ROP in premature infants. Methods and findings In 2 independent, monocentric cohorts of preterm infants born at Conclusions In this study, we observed that exposure to high glucose concentration is an independent risk factor for severe ROP, and we identified cutoff levels that are significantly associated with increased risk. The clinical impact of avoiding exceeding these thresholds to prevent ROP deserves further evaluation., Author(s): Elsa Kermorvant-Duchemin 1,2,3,*, Guylène Le Meur 4, Frank Plaisant 5, Laetitia Marchand-Martin 6, Cyril Flamant 7,8, Raphaël Porcher 3,6, Alexandre Lapillonne 1,3, Sylvain Chemtob 9, Olivier Claris 5,10, Pierre-Yves [...]

Published
2020
Full Text
View/download PDF

33. Cerebral near infrared spectroscopy oximetry in extremely preterm infants : phase II randomised clinical trial

Author

Hyttel-Sorensen, Simon, Pellicer, Adelina, Alderliesten, Thomas, Austin, Topun, van Bel, Frank, Benders, Manon, Claris, Olivier, Dempsey, Eugene, Franz, Axel R, Fumagalli, Monica, Gluud, Christian, Grevstad, Berit, Hagmann, Cornelia, Lemmers, Petra, van Oeveren, Wim, Pichler, Gerhard, Plomgaard, Anne Mette, Riera, Joan, Sanchez, Laura, Winkel, Per, Wolf, Martin, and Greisen, Gorm

Published
2015

35. Performance of 11 host biomarkers alone or in combination in the diagnosis of late-onset sepsis in hospitalized neonates: the prospective EMERAUDE study

Author

Pons, Sylvie, primary, Trouillet-Assant, Sophie, additional, Subtil, Fabien, additional, Abbas-Chorfa, Fatima, additional, Cornaton, Elise, additional, Berthiot, Amélie, additional, Galletti, Sonia, additional, Plat, Aurelie, additional, Rapin, Stephanie, additional, Trapes, Laurene, additional, Generenaz, Laurence, additional, Brengel-Pesce, Karen, additional, Callies, Arnaud, additional, Plaisant, Franck, additional, Claris, Olivier, additional, Portefaix, Aurelie, additional, Flamant, Cyril, additional, and Butin, Marine, additional

Published
2022
Full Text
View/download PDF

39. Early skin-to-skin contact and risk of late-onset-sepsis in very and extremely preterm infants.

Author

Le Ray, Isabelle, Kuhn, Pierre, Letouzey, Mathilde, Roué, Jean-Michel, Mitha, Ayoub, Glorieux, Isabelle, Foix-L'Hélias, Laurence, Marchand-Martin, Laetitia, Ancel, Pierre-Yves, Kaminski, Monique, Pierrat, Véronique, the Epipage 2 Neurodevelopmental care writing Group, Arnaud, Catherine, Burguet, Antoine, Cambonie, Gilles, Caeymaex, Laurence, Claris, Olivier, Gire, Catherine, Guillois, Bernard, and Lecomte, Bénédicte

Published
2023
Full Text
View/download PDF

40. Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab

Author

Mulot, Gwenaelle, Benchaib, Mehdi, Plaisant, Frank, Ploin, Dominique, Gillet, Yves, Javouhey, Etienne, Claris, Olivier, Picaud, Jean-Charles, Casalegno, Jean-Sebastien, Butin, Marine, Hôpital Femme Mère Enfant [CHU - HCL] (HFME), Hospices Civils de Lyon (HCL), Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Radiologie [Hôpital Femme Mère Enfant - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Université de Lyon, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), and Hôpital de la Croix-Rousse [CHU - HCL]

Subjects
LRTI, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, palivizumab, Pediatrics, Perinatology and Child Health, cohort study, RSV, bronchiolitis, preterm
Abstract

IntroductionPreterm infants are at risk of lower respiratory tract infections (LRTI), including Respiratory Syncytial Virus (RSV) associated bronchiolitis, for which palivizumab prophylaxis can be proposed. Our aim was to determine risk factors of very severe RSV disease in children born before 34 weeks of gestation.MethodsAmong 2,101 infants born before 34 weeks of gestation in 3 maternity wards between 2012 and 2017, the laboratory confirmed RSV-infected patients requiring hospitalization before 12 months of corrected age were retrospectively included. We collected data about the neonatal period, the palivizumab prophylaxis and the hospitalization for a RSV-related LRTI. LRTI was considered as very severe (VS-LRTI) when patients required invasive or non-invasive positive pressure ventilation.ResultsAmong 86 included patients, 31 met the criteria of VS-LRTI. The VS-LRTI patients had a higher birth gestational age and weight but less heart disease and bronchopulmonary dysplasia. They received palivizumab prophylaxis less frequently than the other patients but the difference was not significant. At the onset of infection, VS-LRTI patients had a younger corrected age for prematurity and presented more frequently with apnea, bradycardia, life-threatening event, hemodynamic failure, hypercapnia. Using logistic regression, the main factor associated with VS-LRTI was a younger corrected age for prematurity at the onset of infection [Odd ratio for each month of corrected age = 0.77 (0.62; 0.93), p = 0.012].ConclusionInfants at the highest risk of VS-LRTI were infants with a younger corrected age for prematurity. Therefore, a better targeting of infants requiring palivizumab prophylaxis and early interventions at hospital discharge could limit VS-LRTI in these infants.

Published
2022
Full Text
View/download PDF

41. Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial

Author

Schmitz, Thomas, primary, Doret-Dion, Muriel, additional, Sentilhes, Loic, additional, Parant, Olivier, additional, Claris, Olivier, additional, Renesme, Laurent, additional, Abbal, Julie, additional, Girault, Aude, additional, Torchin, Héloïse, additional, Houllier, Marie, additional, Le Saché, Nolwenn, additional, Vivanti, Alexandre J, additional, De Luca, Daniele, additional, Winer, Norbert, additional, Flamant, Cyril, additional, Thuillier, Claire, additional, Boileau, Pascal, additional, Blanc, Julie, additional, Brevaut, Véronique, additional, Bouet, Pierre-Emmanuel, additional, Gascoin, Géraldine, additional, Beucher, Gaël, additional, Datin-Dorriere, Valérie, additional, Bounan, Stéphane, additional, Bolot, Pascal, additional, Poncelet, Christophe, additional, Alberti, Corinne, additional, Ursino, Moreno, additional, Aupiais, Camille, additional, Baud, Olivier, additional, Boize, Philippe, additional, Garabédian, Charles, additional, Flamein, Florence, additional, Le Lous, Maela, additional, Beuchée, Alain, additional, Gondry, Jean, additional, Tourneux, Pierre, additional, Coste-Mazeau, Perrine, additional, Bedu, Antoine, additional, Gallot, Denis, additional, Coste, Karen, additional, Chauleur, Céline, additional, Patural, Hugues, additional, Kayem, Gilles, additional, Mitanchez, Delphine, additional, Heckenroth, Hélène, additional, Boubred, Farid, additional, Sibiude, Jeanne, additional, Desfrère, Luc, additional, Bohec, Caroline, additional, Mansir, Thierry, additional, Koch, Antoine, additional, Kuhn, Pierre, additional, Tillouche, Nadia, additional, Lapeyre, Fabrice, additional, Perrotin, Franck, additional, Favrais, Géraldine, additional, Lecarpentier, Edouard, additional, Durrmeyer, Xaxier, additional, Equy, Véronique, additional, Debillon, Thierry, additional, Rigonnot, Luc, additional, Lefoulgoc, Stéphanie, additional, Brie, Claudia, additional, Pagès, Anne-Sophie, additional, Rayssiguier, Romy, additional, Cambonie, Gilles, additional, Cudeville, Corinne, additional, Madeleneau, Doriane, additional, Morel, Olivier, additional, Hascoet, Jean-Michel, additional, Letouzey, Vincent, additional, Di Maio, Massimo, additional, Salomon, Laurent J., additional, and Lapillonne, Alexandre, additional

Published
2022
Full Text
View/download PDF

43. Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age:A post hoc analysis of the SafeBoosC II trial

Author

Plomgaard, Nne Mette, Schwarz, Christoph E., Claris, Olivier, Dempsey, Eugene M., Fumagalli, Monica, Hyttel-Sorensen, Simon, Lemmers, Petra, Pellicer, Adelina, Pichler, Gerhard, Greisen, Gorm, Plomgaard, Nne Mette, Schwarz, Christoph E., Claris, Olivier, Dempsey, Eugene M., Fumagalli, Monica, Hyttel-Sorensen, Simon, Lemmers, Petra, Pellicer, Adelina, Pichler, Gerhard, and Greisen, Gorm

Abstract

BackgroundThe SafeBoosC II, randomised clinical trial, showed that the burden of cerebral hypoxia was reduced with the combination of near infrared spectroscopy and a treatment guideline in extremely preterm infants during the first 72 hours after birth. We have previously reported that a high burden of cerebral hypoxia was associated with cerebral haemorrhage and EEG suppression towards the end of the 72-hour intervention period, regardless of allocation. In this study we describe the associations between the burden of cerebral hypoxia and the 2-year outcome.MethodsCerebral oxygenation was continuously monitored from 3 to 72 hours after birth in 166 extremely preterm infants. At 2 years of age 114 of 133 surviving children participated in the follow-up program: medical examination, Bayley II or III test and the parental Ages and Stages Questionnaire. The infants were classified according to the burden of hypoxia: within the first three quartiles (n = 86, low burden) or within in the 4(th) quartile (n = 28, high burden). All analyses were conducted post hoc.ResultsThere were no statistically significant differences between the quantitative assessments of neurodevelopment in the groups of infants with the low burden of cerebral hypoxia versus the group of infants with the high burden of cerebral hypoxia. The infants in the high hypoxia burden group had a higher-though again not statistically significant-rate of cerebral palsy (OR 2.14 (0.33-13.78)) and severe developmental impairment (OR 4.74 (0.74-30.49).ConclusionsThe burden of cerebral hypoxia was not significantly associated with impaired 2-year neurodevelopmental outcome in this post-hoc analysis of a feasibility trial.

Published
2022

44. Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial

Author

MS Neonatologie, Child Health, Regenerative Medicine and Stem Cells, Plomgaard, Anne Mette, Schwarz, Christoph E, Claris, Olivier, Dempsey, Eugene M, Fumagalli, Monica, Hyttel-Sorensen, Simon, Lemmers, Petra, Pellicer, Adelina, Pichler, Gerhard, Greisen, Gorm, MS Neonatologie, Child Health, Regenerative Medicine and Stem Cells, Plomgaard, Anne Mette, Schwarz, Christoph E, Claris, Olivier, Dempsey, Eugene M, Fumagalli, Monica, Hyttel-Sorensen, Simon, Lemmers, Petra, Pellicer, Adelina, Pichler, Gerhard, and Greisen, Gorm

Published
2022

45. Delivery room deaths of extremely preterm babies: an observational study

Author

Durrmeyer, Xavier, Scholer-Lascourrèges, Claire, Boujenah, Laurence, Bétrémieux, Pierre, Claris, Olivier, Garel, Micheline, Kaminski, Monique, Foix-LʼHelias, Laurence, Caeymaex, Laurence, Azria, Elie, Beuchée, Alain, Boileau, Pascal, Charlot, Frédérique, Coquelin, Anaëlle, Diguisto, Caroline, Foix LʼHélias, Laurence, Kuhn, Pierre, Levaillant, Cerise, Rouget, Florence, Simeoni, Umberto, Tosello, Barthélemy, and Truffert, Patrick

Published
2017
Full Text
View/download PDF

48. Identifying the target population for primary Respiratory Syncytial Virus two-step prevention in infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN)

Author

Jourdain, Marine, primary, Benchaib, Mehdi, additional, Ploin, Dominique, additional, Gillet, Yves, additional, Javouhey, Etienne, additional, Horvat, Côme, additional, Massoud, Mona, additional, Butin, Marine, additional, Claris, Olivier, additional, Lina, Bruno, additional, and Casalegno, Jean-Sebastien, additional

Published
2022
Full Text
View/download PDF

49. Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial

Author

Plomgaard, Anne Mette, primary, Schwarz, Christoph E., additional, Claris, Olivier, additional, Dempsey, Eugene M., additional, Fumagalli, Monica, additional, Hyttel-Sorensen, Simon, additional, Lemmers, Petra, additional, Pellicer, Adelina, additional, Pichler, Gerhard, additional, and Greisen, Gorm, additional

Published
2022
Full Text
View/download PDF

50. Leading causes of preterm delivery as risk factors for intraventricular hemorrhage in very preterm infants: results of the EPIPAGE 2 cohort study

Author

Arnaud, Catherine, Baud, Olivier, Bednarek, Nathalie, Claris, Olivier, Flamant, Cyril, Gire, Catherine, Saliba, Elie, Brissaud, Olivier, Charkaluk, Marie Laure, Favrais, Geraldine, Bodeau-Livinec, Florence, Chevallier, Marie, Debillon, Thierry, Pierrat, Veronique, Delorme, Pierre, Kayem, Gilles, Durox, Mélanie, Goffinet, François, Marret, Stephane, and Ancel, Pierre Yves

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results